Recombination in the substrate recognition domain of TcdB confers a variant glucosyltransferase activity and a distinctive cytopathic effect to a Clostridium difficile strain from the hypervirulent clade II
purification, cells treated with TcdB of the NAP1V strain (TcdBV), displayed a rounded and surface detached phenotype resembling that induced by C. difficile TcdB toxin A-negative strains. The effect ... along with…

